首页> 外文期刊>中华医学杂志(英文版) >Effect of resection following downstaging of unresectable hepatocelluar carcinoma by transcatheter arterial chemoembolization
【24h】

Effect of resection following downstaging of unresectable hepatocelluar carcinoma by transcatheter arterial chemoembolization

机译:经导管动脉化疗栓塞降级无法切除的肝细胞癌后的切除效果

获取原文
获取原文并翻译 | 示例
           

摘要

Background This retrospective study was undertaken to analyze the outcome of hepatic resection in fifty-two patients with unresectable hepatocellular carcinoma (HCC) between January 2004 and December 2008.Methods Among these fifty-two patients,the mean diameter of the tumor was 7.9 cm (4.4-15.5 cm,median 8.5 cm) prior to the first transcatheter arterial chemoembolization (TACE).After 1-6 times of TACE (median 2),the median tumor diameter was reduced to 4.2 cm (0-8.4 cm) prior to resection.The duration between the last TACE treatment and sequential resection varied from one to six months (median 2.7 months).Serum α-fetoprotein (AFP) levels were abnormal in thirty-eight out of the fifty-two patients.In AFP producing HCCs,AFP levels returned to normal (≤400 μg/L) in twenty-five out of thirty-eight patients.Hepatic segmentectomy,multiple hepatic segmentectomy or partial hepatic resection were performed in forty-five patients,two underwent extended left hemihepatectomy,and one underwent right posterior branch portal vein thrombectomy.One patient received a right hemihepatectomy and three had left hemihepatectomies.Results Complete tumor radiological response (CR) occurred in five patients (9.6%).There were three cases of perioperative mortality in the fifty-two patients (5.8%).One patient underwent salvaged orthotopic liver transplantation,and twenty-one patients observed tumor recurrence within two years.The 1-,3- and 5-year survival rates of the fifty-two patients were 77.0% (n=40),55.0% (n=29),and 52.0% (n=28),respectively.The median survival time after surgery was 49 months (95% confidence interval 7.5-52.7 months).Conclusions TACE treatment provides a better chance for HCC resection in patients initially diagnosed with unresectable HCC.Furthermore,liver resection should be performed once the tumor is downstaged to be compatible for successful resection
机译:背景这项回顾性研究旨在分析2004年1月至2008年12月间52例不可切除的肝细胞癌(HCC)患者的肝切除结果。方法在这52例患者中,肿瘤的平均直径为7.9 cm(第一次经导管动脉化疗栓塞(TACE)前为4.4-15.5 cm,中位8.5 cm).TACE的1-6倍(中位2)后,中位肿瘤直径在切除前减小为4.2 cm(0-8.4 cm)最后一次TACE治疗和顺序切除之间的持续时间从一到六个月不等(中位数2.7个月).52例患者中有38例血清α-甲胎蛋白(AFP)水平异常。 38例患者中有25例的AFP水平恢复到正常水平(≤400μg/ L)。45例患者进行了肝段切除术,多段肝段切除术或部分肝切除术,其中2例行了扩大的左半肝切除术,其中1例进行了钻机后路门静脉血栓切除术。一名患者接受了右半肝切除术,三名接受了左半肝切除术。结果5例患者(9.6%)发生了完全的肿瘤放射学反应(CR)。52例患者中有3例围手术期死亡( 5.8%)。一名患者接受了原位肝移植抢救,其中21名患者在两年内观察到了肿瘤复发。52名患者的1年,3年和5年生存率为77.0%(n = 40)。分别为55.0%(n = 29)和52.0%(n = 28)。手术后中位生存时间为49个月(95%置信区间7.5-52.7个月)。结论TACE治疗为HCC切除提供了更好的机会最初被诊断为不可切除的肝癌的患者。此外,一旦肿瘤降级,应行肝切除术以确保成功切除

著录项

  • 来源
    《中华医学杂志(英文版)》 |2012年第2期|197-202|共6页
  • 作者单位

    Department of Hepatobillary Surgery, General Hospital of Chinese People's Liberation Army, Beijing 100853, China;

    Department of Hepatobillary Surgery, General Hospital of Chinese People's Liberation Army, Beijing 100853, China;

    Department of Intervention Radiology, General Hospital of Chinese People's Liberation Army, Beijing 100853, China;

    Department of Pathology, General Hospital of Chinese People's Liberation Army, Beijing 100853, China;

    Department of Radiology, General Hospital of Chinese People's Liberation Army, Beijing 100853, China;

    Department of Hepatobillary Surgery, General Hospital of Chinese People's Liberation Army, Beijing 100853, China;

    Department of Hepatobillary Surgery, General Hospital of Chinese People's Liberation Army, Beijing 100853, China;

    Department of Hepatobillary Surgery, General Hospital of Chinese People's Liberation Army, Beijing 100853, China;

  • 收录信息 中国科学引文数据库(CSCD);中国科技论文与引文数据库(CSTPCD);
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号